Tuberous sclerosis protein 2 (TSC2) modulates CCN4 cytoprotection during apoptotic amyloid toxicity in microglia

Yan Chen Shang1, Zhao Zhong Chong, Shaohui Wang

  • 1Laboratory of Cellular and Molecular Signaling, New Jersey Health Sciences University, Newark, NJ 07101, USA.

Insights

Wnt1 inducible signaling pathway protein 1 (WISP1/CCN4) influences key proteins in Alzheimer's disease (AD) pathology. WISP1 regulates cell survival pathways, offering potential new therapeutic targets for AD and cognitive loss.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Cell Biology

Background:

  • Alzheimer's disease (AD) affects millions globally, with β-amyloid (Aβ) toxicity being a key pathological feature.
  • Current treatments for AD targeting Aβ toxicity are limited, necessitating novel drug development strategies.

Purpose of the Study:

  • To investigate the role of Wnt1 inducible signaling pathway protein 1 (WISP1/CCN4) in the molecular pathways implicated in AD.
  • To elucidate how WISP1 influences cellular responses to Aβ exposure.

Main Methods:

  • Western blotting to assess protein phosphorylation.
  • Gene silencing techniques (siRNA) to manipulate WISP1 and TSC2 expression.
  • Apoptosis assays (phosphatidylserine exposure, DNA degradation, mitochondrial depolarization, cytochrome c release) in microglia exposed to Aβ.

Main Results:

  • WISP1 modulates the phosphorylation of Akt1, p70S6K, and AMP-activated protein kinase (AMPK).
  • WISP1 influences the phosphorylation of tuberous sclerosis complex 2 (TSC2) at Ser1387 (AMPK target) and Thr1462 (Akt1 target).
  • WISP1-mediated reduction in TSC2 activity enhances p70S6K activity, but TSC2 activity is crucial for WISP1-induced cytoprotection against Aβ toxicity in microglia.

Conclusions:

  • WISP1 plays a significant role in regulating cellular signaling pathways relevant to AD pathogenesis.
  • WISP1's cytoprotective effects against Aβ toxicity are dependent on a basal level of TSC2 activity, potentially involving mTOR signaling.
  • WISP1 represents a potential therapeutic target for mitigating Aβ-induced neurotoxicity in Alzheimer's disease.

Related Concept Videos

Microtubule Associated Proteins (MAPs)01:42

Microtubule Associated Proteins (MAPs)

Microtubule function and architecture are regulated by an array of specialized proteins called microtubule-associated proteins or MAPs. These proteins are widespread across different organisms and have conserved protein motifs, like the multi-TOG domain for tubulin binding found in the CLASP family of MAPs. Some MAPs are lineage-specific based on their conserved domains. Their functions depend upon the cytoskeletal architecture and cell type they are located within. In-plant cells, a specific...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...